Thomas Maddalena

Cardiorenal Sales Specialist at Bayer Pharmaceuticals

Lansing, Michigan, United States

About

Applies knowledge and understanding of health care industry trends, applicable laws, and market conditions and managed care environment into business plans and daily activities. Fosters team effectiveness and accomplishment of shared goals by sharing knowledge, experience and information. Identifies and cultivates relationships within assigned customer base to enhance scope of influence. Sales performance includes Ten (10) President’s Club/Winner’s Circle awards. Experience selling in multiple therapeutic areas including; Oncology, Anti-Infective, Cardiovascular, Diabetes, Anti-viral, Gastroenterology, Hepatitis A & B Vaccines, and Psychiatric medicines in both the Hospital and office based markets. Consistently demonstrates leadership, initiative, teamwork and adaptability. Specialties: Specialty Pharmacy, Monoclonal Antibodies, Biologic’s, Strategic Market Positioning, Key Client Retention, Referral Network Development, Competitive Analysis, Team Building, Leadership and Mentoring, Business Planning.

Experience

  • Cardiorenal Sales Specialist at Bayer Pharmaceuticals
    May 2021 - Present · 5 yrs 2 mos

  • Cardiovascular Specialty Representative at Syneos Health Commercial Solutions
    Jan 2021 - May 2021 · 5 mos

  • Territory Manager at Esperion - The Lipid Management Company
    Feb 2020 - Jan 2021 · 1 yr

  • Sr. Cardiovascular Specialty Representative at Sanofi
    Mar 2015 - Feb 2020 · 5 yrs

    Responsible for achieving sales quota, including market volume, market share growth and business objectives within assigned Territory. Direct promotion of monoclonal antibody Praluent (alirocumab) and anti arrhythmic Multaq (dronedarone) to Cardiologists in West Michigan. Duties include working with specialty pharmacy accounts and dealing with complex reimbursement situations.

  • Sr. Diabetes Sales Specialist at AstraZeneca
    Jul 2013 - Mar 2015 · 1 yr 9 mos

    Responsible for achieving sales quota, including market volume, market share growth and business objectives within assigned Territory. Direct promotion of injectable GLP-1 receptor agonist, SGLT-2 inhibitor therapies.